The Feature

That Pill You Took? It May Well Be Teva’s

for The New York Times

Last year, the company’s medicines filled nearly 630 million prescriptions in the United States, making it a larger domestic supplier than such pharmaceutical heavyweights as Pfizer, Novartis and Merck — combined. And as low-cost generics continue to make inroads with consumers, Teva occupies a pivotal position in a health care industry undergoing seismic changes that will give millions of more patients access to medicine.